ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Psychosocial Treatment for Attention Deficit Hyperactivity Disorder in Adults

Not Applicable

Completed

Conditions: Attention Deficit Disorder With Hyperactivity

Interventions: Behavioral: Meta-Cognitive Therapy
Behavioral: Supportive Therapy

First Posted Date: 2006-01-18

Last Posted Date: 2017-04-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 88

Registration Number: NCT00278473

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Topiramate in the Treatment of Pathological Gambling

Phase 3

Terminated

Conditions: Pathological Gambling

Interventions: Drug: Placebo
Drug: Topiramate

First Posted Date: 2005-10-28

Last Posted Date: 2019-07-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 42

Registration Number: NCT00245583

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Treatment of Post-Traumatic Brain Injury (TBI) Depression

Phase 2

Completed

Conditions: Depression

Interventions: Drug: Sertraline
Drug: Placebo

First Posted Date: 2005-10-05

Last Posted Date: 2015-11-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 52

Registration Number: NCT00233103

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Patient Centered Randomized Controlled Trial

Not Applicable

Completed

Conditions: Early-Stage Breast Cancer

Interventions: Behavioral: Patient Assistance
Behavioral: Information only

First Posted Date: 2005-10-05

Last Posted Date: 2013-12-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 374

Registration Number: NCT00233077

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
Metropolitan Hospital, New York, New York, United States
🇺🇸
Queens Hospital Center, Queens, New York, United States

and more 5 locations

Post-Traumatic Brain Injury (Post-TBI) Fatigue and Its Treatment

Phase 2

Terminated

Conditions: Fatigue

Interventions: Drug: Modafinil
Drug: Placebo

First Posted Date: 2005-10-05

Last Posted Date: 2016-04-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 21

Registration Number: NCT00233090

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program

Not Applicable

Completed

Conditions: Traumatic Brain Injury

Interventions: Other: cognitive rehabilitation day treatment program
Behavioral: Top Down

First Posted Date: 2005-10-05

Last Posted Date: 2013-09-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 77

Registration Number: NCT00233129

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Treatment of Post-TBI Depression

Not Applicable

Completed

Conditions: Traumatic Brain Injury
Depression

Interventions: Behavioral: Cognitive behavioral therapy
Behavioral: Supportive psychotherapy

First Posted Date: 2005-09-21

Last Posted Date: 2013-09-24

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 75

Registration Number: NCT00211835

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

CBT as an Adjunct to SRIs in the Treatment of BDD

Phase 4

Terminated

Conditions: Body Dysmorphic Disorder

Interventions: Behavioral: Cognitive Behavioral Therapy
Drug: Venlafaxine

First Posted Date: 2005-09-21

Last Posted Date: 2017-03-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 17

Registration Number: NCT00211809

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

Use of Functional Behavioral Assessments to Evaluate Stereotypy and Repetitive Behaviors in a Double-blind, Placebo Controlled Trials of Various Medications Used to Treat Children With Autism.

Completed

Conditions: Autism

First Posted Date: 2005-09-21

Last Posted Date: 2013-06-12

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 144

Registration Number: NCT00211770

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Functional Magnetic Resonance Imaging (fMRI) for the Study of Response Inhibition, and Face and Linguistic Processing in Autism

Completed

Conditions: Autism
Asperger's Syndrome

Interventions: Procedure: fMRI

First Posted Date: 2005-09-21

Last Posted Date: 2012-06-28

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 71

Registration Number: NCT00211783

Locations: 🇺🇸
Mount Sinai School of Medicine, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy